TRIP REPORT MINISTERIAL MISSION TO MINNEAPOLIS December 8 – 10, 2008 Overview: Minnesota is a national and international leader in groundbreaking scientific research and innovation in the healthcare and life sciences industries. The life science industry is extremely important to the state of Minnesota’s economy employing more than 250,000 in nearly 600 organizations in numerous fields (medical devices, pharmaceuticals, agricultural and industrial biotechnology, and renewable energy). The mission to the Minneapolis- St. Paul region was anchored with the Life Sciences Alley Conference and Expo, the largest biotechnology event in Midwestern USA. Mission planning was done by Alberta Advanced Education and Technology in collaboration with Trade Team Alberta and participants included 18 Alberta companies. Major partners and contributors for the mission included the Alberta government departments of Advanced Education and Technology, International and Intergovernmental Relations, Finance and Enterprise; Western Economic Diversification Canada; and Edmonton Economic Development Corporation. Mission Objectives: The Alberta mission was undertaken to facilitate growth of Alberta’s knowledge-based industry sectors through expanded opportunities in the USA. A key growth factor is increasing awareness of the province’s innovation capacity and highlighting our areas of strength in biomedical engineering, cardiovascular, and imaging. Minister Horner met with leading industry representatives and investors to attract research and development investments from major US companies, promote partnerships, and develop networks for technology, expertise, and capital sourcing. Results: Tuesday, December 9 Minneapolis Breakfast with the Alberta Delegation Met with 30 representatives from Alberta research institutions and life science industry to interact and engage with members of the mission to reinforce the mission’s objectives. Provided an update on Alberta’s Action Plan: Bringing Technology to Market and discussed opportunities for collaboration with US companies. Meeting with Bracco Imaging and Acist Medical Systems Inc. (Bracco-Acist) Discussed infrastructure and capabilities in Alberta for biomedical engineering, health product development, and clinical trials. Explored three major areas of potential collaboration with Bracco-Acist: multimodal imaging including software development, interpretative imaging, and soft tissue visualization. Meeting with Bose Corporation Electroforce Systems Group (Bose) Discussed potential synergies between corporate research needs, Alberta biomedical engineering, and product development capabilities. Supported the University of Calgary’s discussion with Bose to determine opportunities for collaborative research and the Centre for Integrated Biomedical Technology. Venture Capital and Investor roundtable and luncheon Delivered a keynote speech to over 40 Minnesota and area investors describing Alberta’s history of innovation and industry success and the new Action Plan for Bringing Technology to Market. Discussed the features, advantages, and benefits of collaborating with Alberta and described potential opportunities for commercialization partnerships and investment attraction. Meeting with Otoka Energy (Otoka) Met with senior executives and discussed Otoka’s present activities in Alberta and future development of their Drayton Valley biogas facility (announced January 14, 2009), opportunities to collaborate with feedstock providers, and Alberta’s Nine-Point Bioenergy plan. VIP Reception of Life Science Alley As the sponsor of the main networking event at the Life Science Ally Conference and Expo, the Alberta government heightened the profile of the delegation to create greater exposure and networking opportunities for our life science sector. Minister Horner addressed over 200 senior life sciences executives who attended the conference, including keynote speakers Nobel Laureate, Peter Agre, MD, Director Johns Hopkins Malaria Research Institute and Paul Keckley, PhD, Executive Director of the Deloitte Center for Health Solutions. Wednesday December 10, 2008 Meeting with Medtronic Met with senior executives from Medtronic, the world’s largest medical device company, to discuss Medtronic’s long history of supporting cardiovascular clinical research at the Libin Cardiovascular Institute of Alberta in Calgary. Explored the challenges of initiating large international clinical research trials and discussed opportunities for additional collaborations with Alberta research and technology organizations in Medtronic’s target areas of cardiovascular, bone and joint, and neurological medical devices.